Influenza and Other Respiratory Viruses

Article	Citations
Issue Information	226
	76
	76
Issue Information	70
Cross‐Reactive Antibody Responses to Coronaviruses Elicited by SARS‐CoV‐2 Infection or Vaccination	68
Lower cognitive scores among toddlers in birth cohorts with acute respiratory illnesses, fevers, and laboratory‐confirmed influenza	56
Comparative Effectiveness of Baloxavir Marboxil and Oseltamivir Treatment in Reducing Household Transmission of Influenza: A Post Hoc Analysis of the BLOCKSTONE Trial	50
Antibiotic prescription for outpatients with influenza and subsequent hospitalisation: A cohort study using insurance data	49
Avian Influenza Virus (H5N1) Was Not Detected Among Dairy Cattle and Farm Workers in Pakistan	46
SARS‐CoV‐2 infection rate in Antananarivo frontline health care workers, Madagascar	44
A comparative immune response to COVID‐19 vaccination between children and adults	40
Comparative complete scheme and booster effectiveness of COVID‐19 vaccines in preventing SARS‐CoV‐2 infections with SARS‐CoV‐2 Omicron (BA.1) and Delta (B.1.617.2) variants: A case–case study based on	38
EMARIS Conference 2023: Convergence of science, policy, and practice on acute respiratory infections in post COVID‐19 Eastern Mediterranean Region	38
Risk factors and medical resource utilization in US adults hospitalized with influenza or respiratory syncytial virus in the Hospitalized Acute Respiratory Tract Infection study	36
Predicting virologically confirmed influenza using school absences in Allegheny County, Pennsylvania, USA during the 2007‐2015 influenza seasons	36
Infection‐induced seroconversion and seroprevalence of SARS‐CoV‐2 among a cohort of children and youth in Montreal, Canada	35
A novel household‐based patient outreach pilot program to boost late‐season influenza vaccination rates during the COVID‐19 pandemic	35
Next‐Generation Sequencing for Characterizing Respiratory Tract Virome and Improving Detection of Viral Pathogens in Children With Pneumonia	32
Evaluating Bacillus Calmette–Guérin Polysaccharide Nucleic Acid as an Adjuvant for Influenza Vaccines in Mice	32
No evidence for HPAI H5N1 2.3.4.4b incursion into Australia in 2022	29
Effectiveness of XBB.1.5 Monovalent COVID‐19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS‐EHR Network Study	29
Severe acute respiratory syndrome coronavirus 2 can be detected in exhaled aerosol sampled during a few minutes of breathing or coughing	29
Antigenic Characterization of H1N1 Influenza Viruses That Circulated During the 2019–2020 Season in Philadelphia, Pennsylvania	28
Low prevalence of seasonal influenza viruses in Hong Kong, 2022	27
Antibody titres elicited by the 2018 seasonal inactivated influenza vaccine decline by 3 months post‐vaccination but persist for at least 6 months	27

Effectiveness of the XBB.1.5 COVID‐19 Vaccines Against SARS‐CoV‐2 Hospitalisation Among Adults Aged ≥ 65 Years During the BA.2.86/JN.1 Predominant Period, VEBIS Hospital Study, Europe, November 2023 t	27
Meeting Report: Controlled Human Influenza Virus Infection Model Studies: Current Status and Future Directions for Innovation	26
Tracking Seasonal Influenza Trends in South Tyrol During 2022/2023 Using Genomic Surveillance Data	25
	25
Correction to: The Respiratory Syncytial Virus Prefusion F Protein Vaccine Attenuates the Severity of RSV‐Associated Disease in Breakthrough Infections in Adults ≥60 Years of Age	24
Examining the Influenza A Virus Sialic Acid Binding Preference Predictions of a Sequence‐Based Convolutional Neural Network	23
Issue Information	22
Determination of respiratory syncytial virus epidemic seasons by using 95% confidence interval of positivity rates, 2011–2021, Germany	22
Inno4Vac Workshop Report Part 2: RSV‐Controlled Human Infection Model (CHIM) Strain Selection and Immune Assays for RSV CHIM Studies, November 2021, MHRA, UK	22
Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain	22
Risk factors for infection with influenza A(H3N2) virus on a US university campus, October–November 2021	21
Coinfection of Influenza A and B and Human OC43 Coronavirus in Normal Human Bronchial Epithelial Cells	21
Descriptive Epidemiology of Travel and Non‐Travel Related SARS‐CoV‐2 Gamma (P.1/501Y.V3) Variant Cases in England, 2021	21
Bidirectional Evolution of SARS‐CoV‐2 Virus in Immunocompromised Hosts	21
Letter to editor regarding the systematic review and meta‐analysis by Coleman et al. on the effectiveness of MF59‐adjuvanted seasonal influenza vaccine in older adults	21
In‐field detection and characterization of B/Victoria lineage deletion variant viruses causing early influenza activity and an outbreak in Louisiana, 2019	21
Change in patterns of hospitalization for influenza during COVID‐19 surges	21
A review of policies and coverage of seasonal influenza vaccination programs in the WHO Eastern Mediterranean Region	20
Human respiratory syncytial virus diversity and epidemiology among patients hospitalized with severe respiratory illness in South Africa, 2012–2015	20
Costs of seasonal influenza vaccination in South Africa	20
Live‐attenuated influenza vaccine effectiveness against hospitalization in children aged 2–6 years, the first three seasons of the childhood influenza vaccination program in England, 2013/14–2015/16	19
Influenza vaccine and subsequent development of zoster	19
Drug use and severe outcomes among adults hospitalized with influenza, 2016–2019	19
An Overview of the H5N1 mRNA Vaccine Pipeline	18
Long‐Distance Avian Migrants Fail to Bring 2.3.4.4b HPAI H5N1 Into Australia for a Second Year in a Row	18
A Strategic Framework of SARS‐CoV‐2 Genomic Surveillance in Bangladesh	18
SARS‐CoV‐2 Seroprevalence Trends in the Netherlands in the Variant of Concern Era: Input for Future Response	18
Results from the second WHO external quality assessment for the molecular detection of respiratory syncytial virus, 2019–2020	18
Coronary and Cerebrovascular Events and Exacerbation of Existing Conditions After Laboratory‐Confirmed Influenza Infection Among US Veterans: A Self‐Controlled Case Series Study	18
Age‐specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands	17
Trends in seroprevalence of SARS‐CoV‐2 and infection fatality rate in the Norwegian population through the first year of the COVID‐19 pandemic	17
	17
The national burden of influenza‐like illness and severe respiratory illness overall and associated with nine respiratory viruses in South Africa, 2013–2015	17
Issue Information	17
Community predictors of COVID‐19 cases and deaths in Massachusetts: Evaluating changes over time using geospatially refined data	16
The Oregon Child Absenteeism Due to Respiratory Disease Study (ORCHARDS): Rationale, objectives, and design	16
Some characteristics of clinical sequelae of COVID‐19 survivors from Wuhan, China: A multi‐center longitudinal study	16
Two‐year trajectories of COVID‐19 symptoms and their association with illness perception: A prospective cohort study in Amsterdam, the Netherlands	16
The burden of the coronavirus disease 2019 virus infection in Burkina Faso: Results from a World Health Organization UNITY population‐based, age‐stratified sero‐epidemiological investigation	15
Factors affecting the transmission of SARS‐CoV‐2 in school settings	15
Issue Information	15
Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network	15
Multi‐decade national cohort identifies adverse pregnancy and birth outcomes associated with acute respiratory illness hospitalisations during the influenza season	15
Issue Information	15
Assessment of Influenza Severity in Bhutan by Using WHO Framework Pandemic Influenza Severity Assessment (PISA): An Implementation Research Study	15
Issue Information	15
Detection of clade 2.3.4.4 highly pathogenic avian influenza H5 viruses in healthy wild birds in the Hadeji‐Nguru wetland, Nigeria 2022	15
Association between SARS‐CoV‐2 infections during pregnancy and preterm live birth	15
Targeting Respiratory Viruses: The Efficacy of Intranasal mRNA Vaccination in Generating Protective Mucosal and Systemic Immunity Against Influenza A (H1N1)	15
Geographic Progression of Infant Respiratory Syncytial Virus Associated Bronchiolitis Across the United States Before and Since the Onset of COVID‐19: Results From Four Health Systems, 2015–2023	15

Interim 2023/2024 Season Influenza Vaccine Effectiveness in Primary and Secondary Care in the United Kingdom	14
Association between COVID‐19 and consistent mask wearing during contact with others outside the household—A nested case–control analysis, November 2020–October 2021	14
Disease Burden of RSV Infections and Bronchiolitis in Young Children (< 5 Years) in Primary Care and Emergency Departments: A Systematic Literature Review	14
Issue Information	14
Acute respiratory infection emergency access in a tertiary care children hospital in Italy, prior and after the SARS‐CoV‐2 emergence	14
Interactions among common non‐SARS‐CoV‐2 respiratory viruses and influence of the COVID‐19 pandemic on their circulation in New York City	14
Knowledge, attitudes, and practices towards seasonal influenza vaccination among pregnant women and healthcare workers: A cross‐sectional survey in Afghanistan	13
Issue Information	13
Effectiveness of first and second COVID‐19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021–July 2022	13
	13
Prevalence of Respiratory Viruses in Children With Acute Respiratory Infections in Shanghai, China, From 2013 to 2022	13
High‐Dose Quadrivalent Influenza Vaccine for Prevention of Cardiovascular and Respiratory Hospitalizations in Older Adults	12
COVID‐19 vaccine effectiveness against hospitalization due to SARS‐CoV‐2: A test‐negative design study based on Severe Acute Respiratory Infection (SARI) sentinel surveillance in Spain	12
Impact of COVID‐19 Nonpharmaceutical Interventions on Respiratory Syncytial Virus Infections in Hospitalized Children	12
Bacterial and viral infections among adults hospitalized with COVID‐19, COVID‐NET, 14 states, March 2020–April 2022	12
Relevance of comorbidities for main outcomes during different periods of the COVID‐19 pandemic	12
Influenza hospitalizations during childhood in children born preterm	12
Domination of influenza vaccine virus strains in Hong Kong, 2021	12
Non‐invasive genomics of respiratory pathogens infecting wild great apes using hybridisation capture	12
BNT162b2 vaccination reduced infections and transmission in a COVID‐19 outbreak in a nursing home in Germany, 2021	12
Comparative hospitalization risk for SARS‐CoV‐2 Omicron and Delta variant infections, by variant predominance periods and patient‐level sequencing results, New York City, August 2021–January 2022	12
Characterization of high pathogenicity avian influenza H5Nx viruses from a wild harbor seal and red foxes in Denmark, 2021 and 2022	12
Applying symptom dynamics to accurately predict influenza virus infection: An international multicenter influenza‐like illness surveillance study	12
Influenza clinical testing and oseltamivir treatment in hospitalized children with acute respiratory illness, 2015–2016	12
First human infection of avian influenza A(H5N6) virus reported in Lao People's Democratic Republic, February–March 2021	12
Genomic Analysis and Tracking of SARS‐CoV‐2 Variants in Gwangju, South Korea, From 2020 to 2022	12
Evaluating the Economic and Epidemiological Impact of RSV Hospitalizations in Southern Austria [Southern Austria Respiratory Syncytial Virus INpatient Investigation (ARNI Study)]	11
Clinical symptoms of SARS‐CoV‐2 breakthrough infection during the Omicron period in relation to baseline immune status and booster vaccination—A prospective multicentre cohort of health professionals	11
Implications of the unexpected persistence of human rhinovirus/enterovirus during the COVID‐19 pandemic in Canada	11
The Detection of Influenza Virus Before and During the COVID‐19 Pandemic in Cameroon	11
Issue Information	11
Influenza surveillance systems using traditional and alternative sources of data: A scoping review	11
Enhancing Omicron Sublineage Neutralization: Insights From Bivalent and Monovalent COVID‐19 Booster Vaccines and Recent SARS‐CoV‐2 Omicron Variant Infections	11
Genetic characterization of influenza A virus subtypes H11N6, H11N7, and H11N9 isolated from free‐grazing ducks, Thailand	11
Respiratory viral detection in the plasma and cerebrospinal fluid (CSF) of young febrile infants	11
Distinct influenza surveillance networks and their agreement in recording regional influenza circulation: Experience from Southeast Michigan	11
Antiviral Effectiveness, Clinical Outcomes, and Artificial Intelligence Imaging Analysis for Hospitalized COVID‐19 Patients Receiving Antivirals	11
Exposure to quadrivalent influenza vaccine during pregnancy: Results from a global pregnancy registry	11
Coronaviruses Among Swine Workers in Northern Vietnam	11
Low Levels of Neutralizing Antibodies Against SARS‐CoV‐2 KP.3.1.1 and XEC in Serum From Seniors in May 2024	10
BNT162b2 Versus mRNA‐1273 Vaccines: Comparative Analysis of Long‐Term Protection Against SARS‐CoV‐2 Infection and Severe COVID‐19 in Qatar	10
An Outbreak of Respiratory Viral Infections in a Professional Ice Hockey Team	10
COVID‐19 outbreaks in aged‐care facilities in Australia	10
Issue Information	10
Rapid and Safe Neutralization Assay for Circulating H5N1 Influenza Virus in Dairy Cows	10
Incidence, hospitalization, and mortality in children aged 5 years and younger with respiratory syncytial virus‐related diseases: A systematic review and meta‐analysis	10
Excess All‐Cause Mortality by Age and Gender During the COVID‐19 Pandemic in the Federation of Bosnia and Herzegovina, Bosnia and Herzegovina: 2020–2022	10
Effect of planned school breaks on student absenteeism due to influenza‐like illness in school aged children—Oregon School District, Wisconsin September 2014–June 2019	10
Analysis of a city‐wide COVID‐19 prevention strategy for aged‐care facilities during third and fifth waves of COVID‐19 in Kyoto City, Kyoto, Japan	10
Unveiling the Spectrum of Respiratory Syncytial Virus Disease in Adults: From Community to Hospital	10
Epidemiologic and Virologic Characteristics of Influenza in Lao PDR, 2016–2023	10
Hospitalisation, morbidity and outcomes associated with respiratory syncytial virus compared with influenza in adults of all ages	10
Inpatient burden of respiratory syncytial virus in children ≤2 years of age in Germany: A retrospective analysis of nationwide hospitalization data, 2019–2022	10
Virological and Clinical Outcomes of Influenza Outpatients Treated With Baloxavir, Oseltamivir, or Laninamivir in the 2023–2024 Season	10
Featured Cover	10
SARS‐CoV‐2 Reverse Zoonosis Among Cats in China: A One Health Investigation	9
Mortality patterns among COVID‐19 patients in two Saudi hospitals: Demographics, etiology, and treatment	9
Issue Information	9
Issue Information	9
Transmission of SARS‐CoV‐2 in standardised first few X cases and household transmission investigations: A systematic review and meta‐analysis	9
Inference of age‐dependent case‐fatality ratios for seasonal influenza virus subtypes A(H3N2) and A(H1N1)pdm09 and B lineages using data from the Netherlands	9
	9
Household transmission of COVID‐19 among the earliest cases in Antananarivo, Madagascar	9
Developing a sampling methodology for timely reporting of population‐based COVID‐19‐associated hospitalization surveillance in the United States, COVID‐NET 2020–2021	9
Functional decline at 1 year in hospitalized elderly pneumonia with SARS‐CoV‐2 Omicron variant: Comparison with the ancestral strain and Alpha variant	9
	9
Estimated mortality due to seasonal influenza in southeast of Iran, 2006/2007 to 2011/2012 influenza seasons	8
Correction to ‘Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain’	8
Establishing a COVID‐19 pandemic severity assessment surveillance system in Ireland	8
Transmissibility of severe acute respiratory syndrome coronavirus 2 among household contacts of coronavirus disease 2019‐positive patients: A community‐based study in India	8
Trends in Hospitalisations for Vaccine Preventable Respiratory Infections Following Emergency Department Presentations in New South Wales, Australia, 2012–2022	8
The role of non‐pharmaceutical interventions on influenza circulation during the COVID‐19 pandemic in nine tropical Asian countries	8
	8
Role of research Laboratories in pandemic and epidemic response in the Eastern Mediterranean Region: Experiences from COVID‐19, avian influenza, and MERS‐CoV	8
Severe acute respiratory illness surveillance for influenza in Kenya: Patient characteristics and lessons learnt	8
Clinical outcomes of COVID‐19 treated with remdesivir across the continuum of care	8
Susceptibility of different cell lines to the novel canine coronavirus CCoV‐HuPn‐2018	8
Change in functional status associated with respiratory syncytial virus infection in hospitalized older adults	8
Temporal Trends in Respiratory Infection Epidemics Among Pediatric Inpatients Throughout the Course of the COVID‐19 Pandemic From 2018 to 2023 in Fukushima Prefecture, Japan	8
Association of Monocyte Count With Lung Function and Exercise Capacity Among Hospitalized COVID‐19 Survivors: A 2‐Year Cohort Study	8

Estimating the serial intervals of SARS‐CoV‐2 Omicron BA.4, BA.5, and BA.2.12.1 variants in Hong Kong	8
State and situation of avian influenza in the Eastern Mediterranean Region	8
Estimated Incidence Rate of Specific Types of Cardiovascular and Respiratory Hospitalizations Attributable to Respiratory Syncytial Virus Among Adults in Germany Between 2015 and 2019	8
Rapid assessment of case recruitment tools to inform integrated surveillance of influenza and other respiratory viruses in Eastern Mediterranean countries	8
A Sanger sequencing protocol for SARS‐CoV‐2 S‐gene	7
	7
Enhanced safety surveillance of GSK's quadrivalent seasonal influenza vaccine in Germany and Spain (2021/2022 season) using an electronic patient‐reported outcome system for vaccine safety remote moni	7
Influenza Epidemiology in Finland During and After the COVID‐19 Pandemic: Surveillance Data Analysis (2019–2024)	7
Record high parainfluenza season in children after relaxation of COVID‐19 restrictions in fall 2021—A nationwide register study in Finland	7
Neurologic Complications of Influenza and Potential Protective Vaccine Effects	7
	7
Incidence of Hospitalization due to Influenza‐Associated Severe Acute Respiratory Infection During 2010–2019 in Bangladesh	7
Prevalence and seasonality of viral respiratory infections in a temperate climate region: A 24‐year study (1997–2020)	7
Cardiac Characteristics of Hospitalized Influenza Patients: An Interim Analysis From the FluHeart Study	7
Seasonal influenza in children: Costs for the health system and society in Europe	7
Epidemiology of acute lower respiratory tract infection hospitalizations in Thai children: A 5‐year national data analysis	7
Seasonal respiratory virus circulation was diminished during the COVID‐19 pandemic	7
The Second Round of a Population‐Based Seroprevalence Study of Anti–SARS‐CoV‐2 Antibodies and COVID‐19 Vaccination Assessment in the Republika Srpska, Bosnia and Herzegovina	7
	7
	7
Modifiable in‐hospital factors for 12‐month global cognition, post‐traumatic stress disorder symptoms, and depression symptoms in adults hospitalized with COVID‐19	7
Molecular Analysis of Human Respiratory Syncytial Virus Group B Strains Isolated in Kenya Before and During the Emergence of Pandemic Influenza A/H1N1	7
Neutralizing and protective murine monoclonal antibodies to the hemagglutinin of influenza H5 clades 2.3.2.1 and 2.3.4.4	7
SARS‐CoV‐2 Viral Load and Cytokine Dynamics Profile as Early Signatures of Long COVID Condition in Hospitalized Individuals	7
Pronounced antibody elevation after SARS‐CoV‐2 BNT162b2 mRNA booster vaccination in nursing home residents	6
Viral co‐infections are associated with increased rates of hospitalization in those with influenza	6
Household transmission investigation: Design, reporting and critical appraisal	6
Investigating confounding in network‐based test‐negative design influenza vaccine effectiveness studies—Experience from the DRIVE project	6
Adverse Effects Related to Paediatric Influenza Vaccination and Its Influence on Vaccination Acceptability. The FLUTETRA Study: A Survey Conducted in the Region of Murcia, Spain	6
SARS‐CoV‐2 Infection Among Nursing Home Healthcare Workers: A Longitudinal Study in North‐Eastern Italy	6
Lessons learned from identifying clusters of severe acute respiratory infections with influenza sentinel surveillance, Bangladesh, 2009–2020	6
Investigating the effects of population density of residence and rural/urban classification on rate of influenza‐like illness symptoms in England and Wales	6
Estimating mortality associated with seasonal influenza among adults aged 65 years and above in China from 2011 to 2016: A systematic review and model analysis	6
Should We Vaccinate Healthcare Workers Against Respiratory Syncytial Virus?	6
Using inpatient electronic medical records to study influenza for pandemic preparedness	6
Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS‐CoV‐2 Infection in Older Adults During the JN.1 Lineage‐Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023–1	6
Sex differences in COVID‐19 symptom severity and trajectories among ambulatory adults	6
Severe Neurological Complications With Influenza in Vietnamese Children	6
Transmissibility and severity of COVID‐19 in a humanitarian setting: First few X investigation of cases and contacts in Juba, South Sudan, 2020	6
Rapid influenza molecular testing in secondary care and influenza surveillance in England: Any impact?	6
Hospitalization rate of respiratory syncytial virus‐associated acute lower respiratory infection among young children in Suzhou, China, 2010–2014	6
Influenza‐associated respiratory illness among five cohorts of pregnant women and their young infants (0–6 months), Bangladesh, 2013–2017	6
Performance of established disease severity scores in predicting severe outcomes among adults hospitalized with influenza—FluSurv‐NET, 2017–2018	6
Technological Barriers to Routine Genomic Surveillance for Vaccine Development Against SARS‐CoV‐2 in Africa: A Systematic Review	6
Epidemiological Shifts in Children Respiratory Pathogens in Shenzhen, China: A Comparative Analysis Before and After the Relaxation of COVID‐19 Non‐Pharmaceutical Interventions	6
The importance of influenza vaccination during the COVID‐19 pandemic	6
Measures of Population Immunity Can Predict the Dominant Clade of Influenza A (H3N2) in the 2017–2018 Season and Reveal Age‐Associated Differences in Susceptibility and Antibody‐Binding Specificity	6
Impact of Nirsevimab on RSV and Non‐RSV Severe Respiratory Infections in Hospitalized Infants	5
Symptom‐based case definitions for COVID‐19: Time and geographical variations for detection at hospital admission among 260,000 patients	5
Excess Respiratory Hospitalisations Associated with Influenza, Respiratory Syncytial Virus and SARS‐CoV‐2 in Singapore from 2015 to 2023	5
WHO's Investigations and Studies, Unity Studies: A global initiative creating equitable opportunities for enhanced surveillance, operational research, capacity building, and global knowledge sharing	5
Distinguishing repeated polymerase chain reaction positivity from re‐infections in COVID‐19	5
Nasal shedding of vaccine viruses after immunization with a Russian‐backbone live attenuated influenza vaccine in India	5
Internationally standardized respiratory viral load testing with limited resources: A derivative‐of‐care calibration strategy for SARS‐CoV‐2	5
Issue Information	5
COVID‐19 Hospitalizations, Vaccine Uptake, Vaccination Guidelines, and Vaccine Availability in Six Middle‐Income Countries and Areas in Europe, May 2022–April 2024	5
The epidemiological pattern of seasonal influenza in four sentinel sites in Iraq	5
Severe viral respiratory infections in the pre‐COVID era: A 5‐year experience in two pediatric intensive care units in Italy	5
Incidence rates of influenza illness during pregnancy in Suzhou, China, 2015–2018	5
Authors respond to Chan et al.	5
Measuring respiratory syncytial virus infection severity in hospitalized children using the Pediatric Respiratory Syncytial Virus Electronic Severity and Outcome Rating System (PRESORS)	5
Estimating SARS‐CoV‐2 infections and associated changes in COVID‐19 severity and fatality	5
Prevalence of chronic conditions and influenza vaccination coverage rates in Germany: Results of a health insurance claims data analysis	5
Post‐Mortem Community Surveillance of COVID‐19: Implementation and Evaluation of a Pilot System in the Funeral Sector in England, UK, January 2021 to February 2022	5
Persistent predominance of the Victoria lineage of influenza B virus during COVID‐19 epidemic in Nanchang, China	5
Predictors of all‐cause mortality among patients hospitalized with influenza, respiratory syncytial virus, or SARS‐CoV‐2	5
Monitoring Influenza C and D Viruses in Patients With Respiratory Diseases in Japan, January 2018 to March 2023	5
Human parainfluenza 2 & 4: Clinical and genetic epidemiology in the UK, 2013–2017, reveals distinct disease features and co‐circulating genomic subtypes	5
Association between population density of residence or rural/urban classification and rate of influenza‐like illness symptoms in England and Wales	5
Evaluating the Impact of Different Methods on the Timing and Duration of RSV Epidemics: Analysis of Surveillance Data From the GERi (Global Epidemiology of RSV in Hospitalized and Community Care) Stud	5
Impact of the COVID‐19 Pandemic on Influenza Circulation During the 2020/21 and 2021/22 Seasons, in Europe	5
A nucleic acid amplification test‐based strategy does not help inform return to work for healthcare workers with COVID‐19	5
COVID‐19 vaccination status and testing rates in Finland—A potential cause for bias in observational vaccine effectiveness analysis	5
Evolution of Influenza A(H3N2) Viruses in Bhutan for Two Consecutive Years, 2022 and 2023	5
	4
Changes in Respiratory Syncytial Virus‐Associated Hospitalisations Epidemiology After Nirsevimab Introduction in Lyon, France	4
Influenza Epidemiology and Vaccine Effectiveness Following Funded Influenza Vaccine in Queensland, Australia, 2022	4
Persistence of racial/ethnic and socioeconomic status disparities among non‐institutionalized patients hospitalized with COVID‐19 in Connecticut, July to December 2020	4
SARS‐CoV‐2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February–December 2022	4
Pilot of asymptomatic swabbing of humans following exposures to confirmed avian influenza A(H5) in avian species in England, 2021/2022	4
Issue Information	4
Delayed respiratory syncytial virus outbreak in 2020 in Taiwan was correlated with two novel RSV‐A genotype ON1 variants	4
Intranasal antisepsis to reduce influenza virus transmission in an animal model	4
Uptake and impact of vaccinating primary school children against influenza: Experiences in the fourth season of the live attenuated influenza vaccination programme, England, 2016/2017	4
Upsurge of human rhinovirus infection followed by a delayed seasonal respiratory syncytial virus infection in Thai children during the coronavirus pandemic	4
Assessment of Illness Severity in Adults Hospitalized With Acute Respiratory Tract Infection due to Influenza, Respiratory Syncytial Virus, or Human Metapneumovirus	4
The seasonality of respiratory syncytial virus in Western Australia prior to implementation of SARS‐CoV‐2 non‐pharmaceutical interventions	4
Neutrophil CD64 index as a good biomarker for early diagnosis of bacterial infection in pregnant women during the flu season	4
Burden of Respiratory Syncytial Virus (RSV) Infection Among Adults in Nursing and Care Homes: A Systematic Review	4
Issue Information	4
Modeling the impact of COVID‐19 nonpharmaceutical interventions on respiratory syncytial virus transmission in South Africa	4
Respiratory syncytial virus in pediatric influenza‐like illness cases in Lombardy, Northern Italy, during seven consecutive winter seasons (from 2014–2015 to 2020–2021)	4
Convalescent Plasma Therapy in Immunocompromised Patients Infected With the BA.1 or BA.2 Omicron SARS‐CoV‐2	4
Seasonality and Co‐Detection of Respiratory Viral Infections Among Hospitalised Patients Admitted With Acute Respiratory Illness—Valencia Region, Spain, 2010–2021	4
Detection of Respiratory Viruses Other Than SARS‐CoV‐2 in a Large Hospital Laboratory in Rome, Italy, During the Seasons 2016–2017 to 2022–2023	4